Taiwan Positions Itself As Launch Pad To China Market - BioBusiness Asia 2009 Conference
This article was originally published in PharmAsia News
Executive Summary
TAIPEI - Taiwan is making a serious push to create a biosciences hub. The government is not only spending plenty of money but it is also creating a welcoming regulatory environment and a relatively safe legal framework that can take some of the risk out of investing in China, speakers told BioBusiness Asia attendees in Taiwan July 21
You may also be interested in...
Taiwan's Biobusiness Asia Conference Draws Big Pharma Looking For Perfect Biotech Match
TAIPEI - Novo Nordisk's Tomas Land was in Taiwan this week hoping to give money away
Taiwan's Biobusiness Asia Conference Draws Big Pharma Looking For Perfect Biotech Match
TAIPEI - Novo Nordisk's Tomas Land was in Taiwan this week hoping to give money away
Taiwan Liposome Company Nearing IPO After Round Of Financing
HONG KONG - A cash injection from a U.S. venture capital firm may help a Taiwanese developer of drug delivery systems better compete on a global scale as it moves towards an initial public offering